Erlotinib or Gefitinib for Lung Cancer | Now@NEJM
Links shared publicly online about this topic.
- 442total visits
Erlotinib or Gefitinib for Lung Cancer | Now@NEJM
View full resource at blogs.nejm.org
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Tarceva
Most Recently Shared on March 14, 2011 at 5:13 am By:
Cataldo, Gibbons, and Quintas-Cardama NEJM review for teaching: Erlotinib or Gefitinib for Lung Cancer http://flpbd.it/Rdxo, #oncology
Also Shared By:
Effectiveness of erlotinib in advanced non-small c... [Onkologie. 2012] - PubMed - NCBI
ncbi.nlm.nih.gov — “PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 20, 2012 at 11:25 am By:
Effectiveness of erlotinib in advanced non-small cell lung cancer in cases of gefitinib resistance after treatme... http://t.co/FI2xT39G
Oncology Article |
mdlinx.com — “Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutations in patients with non-squamous non-small cell lung cancer receiving gefitinib or erlotinib” View full resource at mdlinx.com
Most Recently Shared on July 27, 2011 at 10:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clinical significance of serum hepatocyte growth factor and epidermal growth factor gene somatic mutat... http://bit.ly/nTf5Kh #oncology
Erlotinib, gefitinib worthy of first-line status in some cases of NSCLC - ONA
oncologynurseadvisor.com — “Two drugs indicated for second- and third-line therapy in persons with advanced non-small-cell lung cancer (NSCLC) appear to be remarkably effective in treating a certain subset of patients.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 25, 2011 at 11:41 am By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Erlotinib, gefitinib worthy of first-line status in some cases of NSCLC http://goo.gl/fb/Wxmmu
Erlotinib And Gefitinib Effective For Certain Lung Cancers, May Improve Quality Of Life, Survival
medicalnewstoday.com — “LSU oncologist Vince D. Cataldo, MD, is the lead author of a review article reporting two chemotherapy drugs now indicated for second and third-line therapy in patients with advanced non-small-cel” View full resource at medicalnewstoday.com
Most Recently Shared on March 14, 2011 at 9:39 am By:
Erlotinib And Gefitinib Effective For Certain Lung Cancers, May Improve Quality Of Life, Survival: LSU oncologis... http://bit.ly/flMc7b
Erlotinib or Gefitinib for Lung Cancer | Now@NEJM
blogs.nejm.org — “The latest article in our Clinical Therapeutics series, Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib, comes from Dr. Vince Cataldo at the” View full resource at blogs.nejm.org
Most Recently Shared on March 11, 2011 at 6:01 pm By:
NEJM: Erlotinib or Gefitinib for Lung Cancer http://bit.ly/ek58rA
Lung Cancer Patients Whose Cancer Progressed After Treatment With EGFR Inhibitors Benefit From Afatinib
medicalnewstoday.com — “Lung cancer patients who have already been treated with the EGFR inhibitors erlotinib or gefitinib seem to gain further benefits in terms of progression-free survival and tumor shrinkage when trea” View full resource at medicalnewstoday.com
Most Recently Shared on October 13, 2010 at 2:54 pm By:
Lung Cancer Patients Whose Cancer Progressed After Treatment With EGFR Inhibitors Benefit From Afatinib: Lung canc... http://mnt.to/f/3L7M
Afatinib Benefits Lung Cancer Patients Whose Cancer Progressed After Treatment With EGFR Inhibitors - Health News - redOrbit
redorbit.com — “Lung cancer patients who have already been treated with the EGFR inhibitors erlotinib or gefitinib seem to gain further benefits in terms of progression-free survival and tumor shrinkage when treated with the new drug afatinib.” View full resource at redorbit.com
Most Recently Shared on October 13, 2010 at 3:41 am By:
Afatinib Benefits Lung Cancer Patients Whose Cancer Progressed After Treatment With EGFR Inhibitors: Lung cancer p... http://bit.ly/dxrgPc
Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors
eurekalert.org — “Lung cancer patients who have already been treated with the EGFR inhibitors erlotinib or gefitinib seem to gain further benefits in terms of progression-free survival and tumor shrinkage when treated with the new drug afatinib, the results of a Phase IIb/III trial show.” View full resource at eurekalert.org
Most Recently Shared on October 12, 2010 at 3:39 pm By:
Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors: ( European So... http://bit.ly/agh9BV
Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors
news-medical.net — “Lung cancer patients who have already been treated with the EGFR inhibitors erlotinib or gefitinib seem to gain further benefits in terms of progression-free survival and tumor shrinkage when treated with the new drug afatinib, the results of a Phase IIb/III trial show.” View full resource at news-medical.net
Most Recently Shared on October 12, 2010 at 8:52 am By:
Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors: Lung cancer p... http://bit.ly/c8R7VJ
Advertisement
Robert S. Miller, MD
@rsm2800
NEJM: Erlotinib or Gefitinib for Lung Cancer http://t.co/OT3Jwuj-->clinical pearls
1 year ago...